Definitive Healthcare Corp. filings document the regulatory disclosures of a public healthcare data and analytics software company. Recent Form 8-K reports furnish quarterly and annual financial-result releases covering revenue, net loss, adjusted profitability measures, cash flow, guidance, and impairment-related disclosures tied to the company’s subscription-based commercial intelligence platform.
The filing record also includes definitive proxy materials for annual stockholder matters, board elections, executive compensation, equity awards, and governance practices. Other material-event filings document board and committee composition changes, executive-role and compensation arrangements, and the termination of a nominating agreement affecting director-designation rights.
Definitive Healthcare Corp. (DH) – Form 3 filing
The filing records the initial beneficial ownership position of newly listed insider Jonathan Paris, who became Chief Legal Officer on 16 June 2025. According to the disclosure, Paris currently reports no direct or indirect ownership of DH securities. An Exhibit 24 Power of Attorney is included, authorising future Section 16 filings on his behalf. No derivatives, options, or other equity instruments are listed. The submission is made on an individual basis and bears a manual signature dated 18 June 2025.
Because no securities are owned and no transactions are reported, the document is largely administrative and carries minimal immediate financial impact for investors.